Business Wire

Coded Agency Celebrates Continued Growth with Rebrand, Internal Promotions and Client Wins

Share

Global modern communications company Coded Agency today announces a highly-anticipated, strategic overhaul of its branding and website following steady growth and innovation into new markets and industries.

Coded Agency, formerly known as codedpr, was founded in 2015 and quickly grew to become a leading agency of record for a range of lifestyle, fashion, beauty, fitness and wellness brands. In 2020, the agency generated a net income increase of 35%, despite an unprecedented global pandemic. Its upward trajectory continues in 2021 with not only a 65% increase in revenue in Q1 and a 50% increase in clients between Q1 and Q2, but a bold, fresh new look, instrumental employee promotions and expansion into Europe with the agency founder’s relocation to France.

The minority-owned, female-founded company renews its namesake as Coded Agency in tandem with a new website and branding designed by Designsake Studio, a San Francisco-based, award-winning and female founded design firm. “Coded Agency gets what it takes to build and support modern brands and we’re proud of our partnership with this women-owned and operated agency,” said Danielle McWaters, Founder & CCO of Designsake Studio.

Reflecting expansion into a more modern approach to communications that extends beyond traditional public relations and standard influencer programming, the new branding and positioning underscores the agency’s abilities to meet the evolving needs of its clients in a fast-changing world. The new website highlights the agency’s broad range of services including PR, influencer and celebrity marketing, event activations, partnerships and endorsements.

“Our goal for the redesign was to create a new brand identity that enhanced the visitor’s digital experience and showcased the results they deliver for their clients,” McWaters explained. “A fresh color palette, eye-catching typography and monochromatic photography communicate the agency’s tailored, edgy and purposeful approach to communications strategy,” McWaters continued.

Coded Agency prides itself on working with purposeful brands that embrace diversity, sustainability, inclusivity and female empowerment, aiming to amplify their stories. Most recently, Coded Agency has partnered with MVMT, premium watches and accessories; Scentbird, luxury fragrance subscription service; and niLuu, sustainably-made, PETA-approved vegan silk loungewear and sleep accessories, among other client wins. In addition, the agency is honored to continue ongoing partnerships with loyal clientele: Alleyoop, beauty and lifestyle brand; Vitality Institute, renowned beauty and wellness brand known for its chemical peel and medical-grade skincare products; and Caleres brands Allen Edmonds, Naturalizer and Blowfish Malibu.

“To meet the agency’s ongoing plans for growth, we have expanded key roles internally and are establishing a global presence with full-time team members located in Los Angeles, New York and France,” said Jennifer Wentzo, Coded Agency’s Founder and CEO. “Synergistic alignment with companies such as our existing client base and partners like Designsake Studio is part of our DNA. We are proud of our redesign and hope it reflects our forward-thinking approach to modern communications.”

Recent promotions include Jules Barker, appointed Vice President from Senior Director, and Jamie Hecht, named New York PR Manager from Senior Account Executive. In their new roles, they will manage agency operations, continue to foster team development, oversee the agency’s diverse client roster and spearhead the agency’s business development and East Coast representation, respectively.

About Coded Agency

Founded in 2015, Coded Agency is a modern, full-service marketing communications agency situated at the intersection of strategy, instinct and hustle. From dynamic startups to legacy brands under publicly traded parent companies in a diverse range of industries, the agency team delivers impactful, meaningful campaigns that help its brands grow. Consistently topping seven figures in annual revenue since 2016, the team dreams about what’s on the horizon while keeping an eye on the bottom line and infuses their work with the passion and dedication that is singular to the entrepreneurial spirit. For more information, visit www.codedagency.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Jennifer Wentzo, Founder & CEO
info@codedagency.com
+1 424 333 2993

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 02:09:00 CEST | Press release

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines,today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio har

HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 22:06:00 CEST | Press release

HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY

Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 18:03:00 CEST | Press release

Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio

Vertex Announces European Commission Approval for KALYDECO ® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 17:43:00 CEST | Press release

Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)

Suzano 2023 annual report on Form 20-F26.4.2024 17:22:00 CEST | Press release

Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/Contact information Hawthorn Advisors suzano@hawthornadvisors.com

HiddenA line styled icon from Orion Icon Library.Eye